Medications

Research helps pave way for newly approved use of drug

Following two decades of research on a group of rare diseases called hypereosinophilic syndrome at Cincinnati Children's Hospital Medical Center, the U.S. Food and Drug Administration has approved the drug Nucala (mepolizumab) ...

Medications

New head lice treatment approved for use in USA

A new prescription head lice treatment, developed by University of Melbourne Associate Professor Vern Bowles, has been given Food and Drug Administration (FDA) approval, allowing it to be sold in the U.S..

page 18 from 24